BPTF and renal cell carcinoma: The enhancer action of low levels of BPTF is weakened, leading to reduced activation of downstream enolase 2 and other glycolytic related enzymes, and ultimately, the glycolytic level of renal cell carcinoma is reduced and distant metastasis is inhibited [150].